Literature DB >> 13826293

Characterization of urinary steroids in adrenal hyperplasia: isolation of metabolites of cortisol, compound S, and desoxycorticosterone from a normotensive patient with adrenogenital syndrome.

H M GANDY, E H KEUTMANN, A J IZZO.   

Abstract

Entities:  

Keywords:  ADRENAL CORTEX HORMONES; ADRENOGENITAL SYNDROME/urine

Mesh：

Substances：

Year:  1960        PMID： 13826293      PMCID： PMC441814          DOI： 10.1172/JCI104047

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  46 in total

1.  A micromethod for the detection and assay of steroid C21 17-hydroxy-alpha-glycols.

Authors:  H WILSON; R FAIRBANKS
Journal:  Arch Biochem Biophys       Date:  1955-02       Impact factor: 4.013

2.  Congenital adrenal hyperplasia with hypertension: unusual steroid pattern in blood and urine.

Authors:  W R EBERLEIN; A M BONGIOVANNI
Journal:  J Clin Endocrinol Metab       Date:  1955-12       Impact factor: 5.958

3.  The excretion of allo tetrahydrocortisol in human urine.

Authors:  I E BUSH; M WILLOUGHBY
Journal:  Biochem J       Date:  1957-12       Impact factor: 3.857

4.  Adrenogenital syndrome: uncomplicated and hypertensive forms.

Authors:  A M BONGIOVANNI
Journal:  Pediatrics       Date:  1958-04       Impact factor: 7.124

5.  Urinary corticosteroid excretion patterns in patients with adrenocortical dysfunction.

Authors:  I DYRENFURTH; S SYBULSKI; V NOTCHEV; J C BECK; E H VENNING
Journal:  J Clin Endocrinol Metab       Date:  1958-04       Impact factor: 5.958

6.  The effect of Reichstein's substance S on the excretion of 17-ketosteroids.

Authors:  G BIRKE
Journal:  Acta Endocrinol (Copenh)       Date:  1954-01

7.  The effects of adrenocorticotropic hormone and cortisone in the adrenogenital syndrome associated with congenital adrenal hyperplasia: an attempt to explain and correct its disordered hormonal pattern.

Authors:  F C BARTTER; F ALBRIGHT; A P FORBES; A LEAF; E DEMPSEY; E CARROLL
Journal:  J Clin Invest       Date:  1951-03       Impact factor: 14.808

8.  Isolation of 17-hydroxycorticosterone from blood obtained from adrenal veins of dogs.

Authors:  H REICH; D H NELSON; A ZAFFARONI
Journal:  J Biol Chem       Date:  1950-11       Impact factor: 5.157

9.  A hypertensive syndrome with relative adrenal cortical overactivity.

Authors:  D F DAVIES; H E CLARK
Journal:  Circulation       Date:  1950-10       Impact factor: 29.690

10.  The excretion of pregnane-3alpha, 17alpha, 21-triol-20-one (tetrahydro S) in normal and pathologic urine.

Authors:  H BULASCHENKO; F C DOHAN; E M RICHARDSON; J C TOUCHSTONE
Journal:  J Clin Endocrinol Metab       Date:  1957-02       Impact factor: 5.958
View more
  7 in total

1.  ADRENO-CORTICAL HYPERACTIVITY--TWO INTERESTING CASES.

Authors:  R W LOGAN; N L MCMILLAN
Journal:  Postgrad Med J       Date:  1964-10       Impact factor: 2.401

Review 2.  Low-renin hypertension of childhood.

Authors:  J DiMartino-Nardi; M I New
Journal:  Pediatr Nephrol       Date:  1987-01       Impact factor: 3.714

Review 3.  Lessons from inborn errors of metabolism.

Authors:  M D Milne
Journal:  Proc R Soc Med       Date:  1966-11

4.  Congenital adrenal hyperplasia due to combined 21- and 11 beta-hydroxylase deficiency.

Authors:  R Penny; P Vecsei
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

5.  INDENTIFICATION OF 3ALPHA, 17ALPHA, 21-TRIHYDROXY-5ALPHA-PREGNANE (ALLOTETRAHYDRO-17ALPHA-HYDROXY-CORTEXONE) AND 3ALPHA, 21-DIHYDROXY-5ALPHA-PREGNANE (ALLO-TETRAHYDRO-CORTEXONE) IN HUMAN URINE.

Authors:  J R PASQUALINI
Journal:  Experientia       Date:  1963-12-15

6.  [Identification of the glucosiduronate of 5beta-pregnane-3alpha,21-diol-20-one (THDOC) after the administration of cortexone].

Authors:  J R PASQUALINI; M F JAYLE
Journal:  Experientia       Date:  1961-10-15

7.  ISOLATION AND IDENTIFICATION OF 3ALPHA,17ALPHA,21TRIHYDROXY-5ALPHA-PREGNAN-20-ONE (ALLO-TETRAHYDRO-COMPOUND S) AFTER ADMINISTRATION OF 3BETA, 17ALPHA,21-TRIHYDROXYPREGN-5-EN-20-ONE(17ALPHA,21-DIHYDROXYPREGNENOLONE).

Authors:  J R PASQUALINI; M F JAYLE
Journal:  Biochem J       Date:  1963-08       Impact factor: 3.857
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.